James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $551.86 ($5.6M) on 2026-04-02, disclosed to the SEC on 2026-04-06.
Scheduled sale ($5.6M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $551.86 | 40 | $22K | 0.4% |
| 2 | $553.99 | 401 | $222K | 4.0% |
| 3 | $555.22 | 778 | $432K | 7.7% |
| 4 | $556.17 | 844 | $469K | 8.4% |
| 5 | $557.05 | 977 | $544K | 9.7% |
| 6 | $558.11 | 720 |
| $402K |
| 7.2% |
| 7 | $559.03 | 240 | $134K | 2.4% |
| 8 | $560.39 | 72 | $40K | 0.7% |
| 9 | $561.75 | 571 | $321K | 5.7% |
| 10 | $563.00 | 555 | $312K | 5.6% |
| 11 | $563.86 | 896 | $505K | 9.0% |
| 12 | $564.82 | 2,201 | $1.2M | 22.1% |
| 13 | $565.99 | 742 | $420K | 7.5% |
| 14 | $566.82 | 323 | $183K | 3.3% |
| 15 | $567.95 | 400 | $227K | 4.0% |
| 16 | $569.75 | 120 | $68K | 1.2% |
| 17 | $571.65 | 120 | $69K | 1.2% |
| Total | $561.50 avg | 10,000 | $5.6M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |